Overexpression of TAZ increased KLF5 and its target FGF-BP expression, while downregulation of TAZ exhibited the opposite effects and retarded growth of 184A1 breast cells and HCC1937 breast cancer cells [68]. The gene discussed is KLF5; the disease is breast cancer.